Inventor · disambiguated record
Aman Trehan
Also filed as: TREHAN AMAN
25 granted patents·13 pending applications·13 citations·filing 2012–2024
92Inventor score
Top patents by PatentIndex Score
38 records- 0196US11298315B2Triamcinolone and moxifloxacin compositionsSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Apr 12, 2022·3 cites·33 claims
- 0294US11969410B2Low pH pilocarpine and brimonidine compound formulations and related methodsSOMERSET THERAPEUTICS LLC·Filed 2023·Granted Apr 30, 2024·1 cites·17 claims
- 0394US11857539B2Gel ophthalmic formulations of pilocarpine and brimonidine compounds and related methodsSOMERSET THERAPEUTICS LLC·Filed 2023·Granted Jan 2, 2024·1 cites·22 claims
- 0493US12156868B2Formulations of pilocarpine and brimonidine compounds and related methodsSOMERSET THERAPEUTICS LLC·Filed 2023·Granted Dec 3, 2024·1 cites·12 claims
- 0590US11696910B2Buffer-free, stable ophthalmological compositions of ketorolac and phenylephrine and applications thereofSOMERSET THERAPEUTICS LLC·Filed 2022·Granted Jul 11, 2023·1 cites·5 claims
- 0688US11564931B2Low benzalkonium chloride bimatoprost ophthalmic compositions with effective penetration and preservation propertiesSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Jan 31, 2023·1 cites·13 claims
- 0787US11400100B2Effective benzalkonium chloride-free bimatoprost ophthalmic compositionsSOMERSET THERAPEUTICS LLC·Filed 2020·Granted Aug 2, 2022·1 cites·29 claims
- 0880US11471403B2Limited particle size triamcinolone and moxifloxacin compositions and associated methods of useSOMERSET THERAPEUTICS LLC·Filed 2022·Granted Oct 18, 2022·0 cites·37 claims
- 0980US11446242B2Suspension component-specific triamcinolone and moxifloxacin compositions and associated methods of useSOMERSET THERAPEUTICS LLC·Filed 2022·Granted Sep 20, 2022·0 cites·33 claims
- 1080US11439591B2Moxifloxacin and triamcinolone compositions and associated methodsSOMERSET THERAPEUTICS LLC·Filed 2022·Granted Sep 13, 2022·0 cites·33 claims
- 1179US9433620B2Pharmaceutical compositions of lurasidoneKHERA BRIJ·Filed 2012·Granted Sep 6, 2016·4 cites·20 claims
- 1277US12042502B2Enhanced penetration ophthalmic compositions of bimatoprost and timololSOMERSET THERAPEUTICS LLC·Filed 2023·Granted Jul 23, 2024·0 cites·19 claims
- 1377US11883382B2Buffer-free ophthalmological compositions of ketorolac and phenylephrine and applications thereofSOMERSET THERAPEUTICS LLC·Filed 2022·Granted Jan 30, 2024·0 cites·19 claims
- 1476US11793789B2Treatment of ophthalmological conditions using buffer-free ophthalmological compositions of ketorolac and phenylephrineSOMERSET THERAPEUTICS LLC·Filed 2022·Granted Oct 24, 2023·0 cites·11 claims
- 1576US11523987B2Trimcinolone and moxifloxacin methodsSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Dec 13, 2022·0 cites·25 claims
- 1674US12064440B2Ophthalmic gel compositions of bimatoprost and timolol and associated methodsSOMERSET THERAPEUTICS LLC·Filed 2023·Granted Aug 20, 2024·0 cites·17 claims
- 1774US2024398760A1Chelated, stable ophthalmological compositions of ketorolac and phenylephrine and applications thereofSOMERSET THERAPEUTICS LLC·Filed 2024·Application pending·0 cites
- 1872US12029729B2Chelated, stable ophthalmological compositions of ketorolac and phenylephrine and applications thereofSOMERSET THERAPEUTICS LLC·Filed 2022·Granted Jul 9, 2024·0 cites·21 claims
- 1971US11786538B2Low benzalkonium chloride bimatoprost ophthalmic compositions with effective penetration and preservation propertiesSOMERSET THERAPEUTICS LLC·Filed 2020·Granted Oct 17, 2023·0 cites·20 claims
- 2071US11382910B2Loteprednol and moxifloxacin compositions and methodsSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Jul 12, 2022·0 cites·31 claims
- 2170US12016855B2Prednisolone and moxifloxacin compositions and methodsSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Jun 25, 2024·0 cites·35 claims
- 2270US11484538B2Bromfenac, prednisolone, and moxifloxacin compositions and methodsSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Nov 1, 2022·0 cites·31 claims
- 2367US11510930B2Gatifloxacin, prednisolone, and bromfenac compositions and methodsSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Nov 29, 2022·0 cites·24 claims
- 2466US2022105100A1Safe brinzolamide and brimonidine compositions with enhanced benzalkonium chloride contentSOMERSET THERAPEUTICS LLC·Filed 2021·Application pending·0 cites
- 2566US2022105103A1Safe use of brinzolamide and brimonidine compositions with enhanced benzalkonium chloride contentSOMERSET THERAPEUTICS LLC·Filed 2021·Application pending·0 cites
- 2665US11857538B2Stable pilocarpine formulations with modified buffer characteristics and related methodsSOMERSET THERAPEUTICS LLC·Filed 2023·Granted Jan 2, 2024·0 cites·20 claims
- 2765US2024252475A1Tiotropium combination product compositions and related methodsSOMERSET THERAPEUTICS LLC·Filed 2024·Application pending·0 cites
- 2864US2024197676A1Ready-to-use ascorbic acid compound compositionsSOMERSET THERAPEUTICS LLC·Filed 2024·Application pending·0 cites
- 2964US2024197675A1Ready-to-use ascorbic acid compound compositionsSOMERSET THERAPEUTICS LLC·Filed 2024·Application pending·0 cites
- 3059US11850249B2Methods of efficiently reducing intraocular pressureSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Dec 26, 2023·0 cites·14 claims
- 3158US12102632B2Quinolone dispersionsSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Oct 1, 2024·0 cites·28 claims
- 3241US2016271120A1Pharmaceutical composition for cleansing of the gastrointestinal tractOAKDENE HOLDINGS LLC·Filed 2016·Application pending·0 cites
- 3341US2016243144A1Fixed dose combination formulations of rifaximin and lactuloseOAKDENE HOLDINGS LLC·Filed 2016·Application pending·0 cites
- 3440US2016243064A1Novel oral pharmaceutical compositions of treprostinilGAVIS PHARMACEUTICALS·Filed 2016·Application pending·0 cites
- 3540US2016263152A1Bowel cleansing composition with improved tasteGAVIS PHARMACEUTICALS·Filed 2016·Application pending·0 cites
- 3638US2016271121A1Antifungal combination therapyGAVIS PHARMACEUTICALS·Filed 2015·Application pending·0 cites
- 3738US2016271058A1Ophthalmic emulsion composition of cyclosporineGAVIS PHARMACEUTICALS·Filed 2015·Application pending·0 cites
- 3838US2016271059A1Ophthalmic emulsion composition of cyclosporineGAVIS PHARMACEUTICALS·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Aman Trehan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →